TechTaffy

tech:

taffy

GENWI Raises $4 Million From Nexus Venture Partners in Series A Funding

By TechTaffy Desk

GENWI  has raised $4 million in Series A funding in a round led by Nexus Venture Partners. GENWI’s existing investors, Inventus Capital Partners and Quest Venture Partners, also participated in the round. Jishnu Bhattacharjee of Nexus Venture Partners will also be joining GenWi’s board of directors.

The latest round of funding brings GENWI’s lifetime funding to $5.1 million, including the original $1.1 million seed round raised in 2010.

PJ Gurumohan (CEO and Founder, GENWI): Our new funding round will be used to build out the infrastructure and an extensive app network to offer more advanced monetization, and distribution features for publishers. A primary focus of the funding efforts will also be a full global expansion of the service, as well as development of multilingual functionality.

 

Just in

Around the web

Windows 11 Start menu ads are now rolling out to everyone — The Verge

Microsoft is starting to enable ads inside the Start menu on Windows 11 for all users, writes Tom Warren. 
Around the web

Biden signs TikTok ‘ban’ bill into law, starting the clock for ByteDance to divest it — The Verge

President Joe Biden signed a foreign aid package that includes a bill that would ban TikTok if China-based parent company ByteDance fails to divest the app within a year, writes Lauren Feiner.
IT

IBM to acquire HashiCorp for $6.4B

IBM and HashiCorp have entered into an agreement for IBM to acquire HashiCorp, a provider of infrastructure and security management products, for $6.4 billion.
AI

OpenAI introduces new enterprise features

OpenAI announced new features aimed at enterprise users on Tuesday, at the wake of Meta's recent LLama 3 announcement.
Around the web

Oracle is moving its world headquarters to Nashville to be closer to health-care industry — CNBC

Oracle Chairman Larry Ellison said Tuesday that the company is moving its world headquarters to Nashville, Tennessee, to be closer to a major health-care epicenter, writes Ashley Capoot.